Filana Therapeutics (FLNA) Gains FDA Clearance to Resume Epilepsy Trial; Market Pricing Reflects Growth Uncertainty
· gurufocus.com
On September 22, 2026, Filana Therapeutics Inc (NASDAQ: FLNA) received FDA clearance to lift the clinical hold on its lead drug candidate simufilam, enabling th
On September 22, 2026, Filana Therapeutics Inc (NASDAQ: FLNA) received FDA clearance to lift the clinical hold on its lead drug candidate simufilam, enabling th...